The Reemergence of Nitrite as a Beneficial Agent in the Treatment of Ischemic Cardiovascular Diseases release_2aodozyoifa3nn5ixg6dyupj2m

by Bobby D Nossaman, Haseeb A Akuly, George F Lasker, Vaughn E Nossaman, Philip A Rothberg, Philip J Kadowitz

Published in Asian journal of experimental biological sciences.

2010   Volume 1, Issue 2, p451-459


Nitrite was a therapeutic agent used in the treatment of angina pectoris and hypertension, but was replaced by nitroglycerin. However, nitrite has recently been rediscovered following observations that this anion possesses novel pharmacologic actions such as producing vasodilation, modulating hypoxic vasodilation, and providing cytoprotection in ischemia-reperfusion injury. Moreover, recent observations in animal and human studies have demonstrated that the reduction of nitrite to vasoactive nitric oxide occurs through both enzymatic and non-enzymatic processes. These findings suggest that nitrite may act as a storage form for nitric oxide and provide support for investigating the use of nitrite in the treatment of ischemic disease states including pulmonary hypertension.
In text/plain format

Archived Files and Locations

application/pdf  372.8 kB
file_ifvg5qcafnh2bnh3vqytz5gmbi (repository) (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2010
Language   en ?
PubMed  20953292
PMC  PMC2955410
Journal Metadata
Open Access Publication
Not in DOAJ
Not in Keepers Registry
ISSN-L:  0975-5845
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: a94fa582-5fcb-4efa-81bd-806b29ec5091